Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
- Status
- COMPLETED
- Phase
- PHASE2
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2